• Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union

    Sep 1, 2018, 00:00

  • Drug Policy in the Russian Federation

    Sep 1, 2018, 00:00

  • Smoking Behavior among Jordanians- Physical, Psychological, Social, and Economic Reasons

    Sep 1, 2018, 00:00

  • Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Evaluations of Oral Anticancer Agents- Systematic Review of Characteristics, Methodological Trends, and Reporting Quality

    Sep 1, 2018, 00:00

  • An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets

    Sep 1, 2018, 00:00

  • Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD—A Cost-Effectiveness Analysis in the Czech Republic

    Sep 1, 2018, 00:00

  • Drug Policy in Greece

    Sep 1, 2018, 00:00

  • Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa- The Interface Between Research Evidence, Policy, and Practice

    Sep 1, 2018, 00:00

  • Copyright/Subscription

    Jul 26, 2018, 13:37

  • Excess Hospitalization Expenses Attributable to Type 2 Diabetes Mellitus in Singapore

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran

    May 1, 2018, 00:00

  • Recent Pricing Negotiations on Innovative Medicines Pilot in China- Experiences, Implications, and Suggestions

    May 1, 2018, 00:00

  • The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia- A Systematic Review

    May 1, 2018, 00:00

  • How Much Does Management of an Asthma-Related Event Cost in a Malaysian Suburban Hospital?

    May 1, 2018, 00:00

  • Health Technology Assessment and Its Use in Drug Policies in China

    May 1, 2018, 00:00

  • Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance

    May 1, 2018, 00:00

  • New Drug Reimbursement and Pricing Policy in Taiwan

    May 1, 2018, 00:00

  • Health-Related Quality of Life of Patients with HPV-Related Cancers in Indonesia

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00

  • The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia

    May 1, 2018, 00:00

  • Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India

    May 1, 2018, 00:00

  • Resource Use and Cost of Treating Human Papillomavirus–Related Lesions in Japanese Women

    May 1, 2018, 00:00

  • Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis- A Study from a Tertiary Care Hospital in Thailand

    May 1, 2018, 00:00

  • A Review of Studies of Quality of Life for Chinese-Speaking Patients with Ischemic Heart Disease

    May 1, 2018, 00:00

  • Table of Contents

    May 1, 2018, 00:00

  • Health Expenditure Growth under Single-Payer Systems- Comparing South Korea and Taiwan

    May 1, 2018, 00:00

  • Cultural Adaptation and Linguistic Validation of the Beliefs about Medicines Questionnaire in Malaysia

    May 1, 2018, 00:00

  • A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients

    May 1, 2018, 00:00

  • Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-Being

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease

    May 1, 2018, 00:00

  • Health Utility of Pregnant Women Living with HIV/AIDS- Prevention of Mother-to-Child Transmission of HIV (PMTCT) Programs in Yunnan Province- A Cross-Sectional Study

    May 1, 2018, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables

    May 1, 2018, 00:00

  • Evaluation of the Long-Term Impact of Improving Care for People with Type 2 Diabetes in China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital

    May 1, 2018, 00:00

  • Conducting and Disseminating Epidemiological Systematic Reviews in Latin America and the Caribbean- Pitfalls and Lessons Learned

    Dec 1, 2017, 00:00

  • HTA Implementation in Latin American Countries- Comparison of Current and Preferred Status

    Dec 1, 2017, 00:00

  • Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia

    Dec 1, 2017, 00:00

  • ViHRI 2017 Reviewer Acknowledgement

    Dec 1, 2017, 00:00

  • Copyright page

    Dec 1, 2017, 00:00

  • Costos medicos directos en pacientes con enfermedad pulmonar obstructiva Crónica en Mexico

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia

    Dec 1, 2017, 00:00

  • A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

    Dec 1, 2017, 00:00

  • Value in Health Regional Issues- PubMed Indexing and Our “Coming of Age”

    Dec 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection- A Short-Term Pharmacoeconomic Evaluation (12 Months)

    Dec 1, 2017, 00:00

  • Burden of Culture-Confirmed Pediatric Pneumococcal Pneumonia in Latin America and the Caribbean- A Systematic Review and Meta-Analysis

    Dec 1, 2017, 00:00

  • ToC

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Single-Use Devices in Argentina- Cost Comparison Analysis of a “Re-Use” versus a “Single-Use” Policy for Trocars, Endocutters, Linear Cutters, and Harmonic Scalpels

    Dec 1, 2017, 00:00

  • Uso de recursos y costos de hospitalizaciones por insufi ciencia card í aca- un estudio retrospective multic é ntrico en Argentina

    Dec 1, 2017, 00:00

  • Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital

    Dec 1, 2017, 00:00

  • Estudio de impacto presupuestal de Daclatasvir asociado a Asunaprevir desde la perspectiva del sistema de salud público chileno

    Dec 1, 2017, 00:00

  • Impacto del incremento del impuesto a los productos de tabaco sobre la recaudación y los precios en Panamá

    Dec 1, 2017, 00:00

  • Doctors Adjacent to Private Pharmacies- The New Ambulatory Care Provider for Mexican Health Care Seekers

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Intracranial Pressure Monitoring in Pediatric Patients with Severe Traumatic Brain Injury- A Simulation Modeling Approach

    Dec 1, 2017, 00:00

  • Evaluación de tecnologías sanitarias para la toma de decisiones y la rendición de cuentas- una urgente reflexión para el sistema de salud chileno

    Dec 1, 2017, 00:00

  • Editorial comment on Health Technology Assessment (HTA)- Good Practices Principles. FIFARMA’s Position on HTA Processes in Latin America- The Devil Is in the Details

    Dec 1, 2017, 00:00

  • Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases- 1998--2015 Period in Turkey

    Sep 1, 2017, 00:00

  • Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets

    Sep 1, 2017, 00:00

  • Concept of Combining Cost-Effectiveness Analysis and Budget Impact Analysis in Health Care Decision-Making

    Sep 1, 2017, 00:00

  • Functional Social Support for Hypertensive Patients in Primary Care Setting in Poland- What Is Expected and What Is Received?

    Sep 1, 2017, 00:00

  • Drug Policy in Latvia

    Sep 1, 2017, 00:00

  • ToC

    Sep 1, 2017, 00:00

  • Drug Policy in Bulgaria

    Sep 1, 2017, 00:00

  • Advancing the Visibility, Impact, and Quality Metrics of Value in Health Regional Issues

    Sep 1, 2017, 00:00

  • Drug Policy in Hungary

    Sep 1, 2017, 00:00

  • Editorial Board

    Sep 1, 2017, 00:00

  • Drug Policy in Slovakia

    Sep 1, 2017, 00:00

  • Synthesizing and Appraising the Quality of the Evidence on Factors Associated with Medication Adherence in Diabetes- A Systematic Review of Systematic Reviews

    Sep 1, 2017, 00:00

  • Copyright Page

    Sep 1, 2017, 00:00

  • Drug Policy in the Czech Republic

    Sep 1, 2017, 00:00

  • Drug Policy in Croatia

    Sep 1, 2017, 00:00

  • Drug Policy in Poland

    Sep 1, 2017, 00:00

  • Drug Policies in Central and Eastern European Countries

    Sep 1, 2017, 00:00

  • Battling Tuberculosis beyond antibiotics

    Sep 1, 2017, 00:00

  • Cost-Effectiveness Analysis of New HCV Treatments in Egyptian Cirrhotic and Non-Cirrhotic Patients- A Societal Perspective

    Sep 1, 2017, 00:00

  • Ebola Virus Epidemic in West Africa- Global Health Economic Challenges, Lessons Learned, and Policy Recommendations

    Sep 1, 2017, 00:00

  • Cost of Osteoporotic Fractures in Singapore

    May 1, 2017, 00:00

  • Cost-Benefit Analysis and Assessment of Quality of Care in patients with Hemophilia undergoing treatment at National Rural Health Mission in Maharashtra, India

    May 1, 2017, 00:00

  • Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea

    May 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial- Taiwanese Perspective

    May 1, 2017, 00:00

  • Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in Japan

    May 1, 2017, 00:00

  • Comparison on Human Resource Requirement between Manual and Automated Dispensing Systems

    May 1, 2017, 00:00

  • Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy- Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene?

    May 1, 2017, 00:00

  • Healthy China 2030- A Vision for Health Care

    May 1, 2017, 00:00

  • Exploring Product-Specific Attributes of a Community Cardiac Rehabilitation Program in an Asian Urban City

    May 1, 2017, 00:00

  • Comparative Study on Health-Related Quality of Life of Farmers and Workers

    May 1, 2017, 00:00

  • Table of Contents

    May 1, 2017, 00:00

  • Is It Time for Joint Health Technology Assessment in Asia? Opportunities and Challenges

    May 1, 2017, 00:00

  • Minimal Clinically Important Differences (MCIDs) of the Thai Version of the Leicester Cough Questionnaire for Subacute and Chronic Cough

    May 1, 2017, 00:00

  • Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients with Painful Bone Metastases- An Iranian Patient’s Perspective Study

    May 1, 2017, 00:00

  • Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital- Evidence from a Cross-Sectional Study

    May 1, 2017, 00:00

  • ViHRI Volume 12 Asia 2017 Reviewer Acknowledgement

    May 1, 2017, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Pediatric Patients (Aged 3 Months to 19 Years) in the Philippines

    May 1, 2017, 00:00

  • Copyright/Subscription page

    May 1, 2017, 00:00

  • The Emerging Role of Patient-Reported Outcomes (PROs) in Clinical Trials- An Indian Perspective

    May 1, 2017, 00:00

  • Translation, Revision, and Validation of the Diabetes Distress Scale for Indonesian Type 2 Diabetic Outpatients with Various Types of Complications

    May 1, 2017, 00:00

  • Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets

    May 1, 2017, 00:00

  • Psychometric Properties of the Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QOL)

    May 1, 2017, 00:00

  • Estimación de la Relación Costo-Efectividad de las Vacunas Neumocócicas Conjugadas Prevenar-13 y Synflorix®, Utilizadas en Los Programas de Vacunación de Población Infantil Mexicana

    Dec 1, 2016, 00:00

  • Análise de Custo-Efetividade do uso do Sistema de Comunicação e Arquivamento de Imagens (PACS) em mamografias digitais

    Dec 1, 2016, 00:00

  • Guide for Authors

    Dec 1, 2016, 00:00

  • Cardiovascular Disease and Health Care System Impact on Functionality and Productivity in Argentina- A Secondary Analysis

    Dec 1, 2016, 00:00

  • 11C Reviewer Acknowledgment

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of the Quantification of Enzymatic Activity in Leukocytes in Comparison to Its Nonrealization for a Rare Disease in Latin America- The Case of Mucopolysaccharidosis Type II in Colombia

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016- brief update

    Dec 1, 2016, 00:00

  • Direct Medical Costs of Chronic Urticaria in a Private Health Organization of Buenos Aires, Argentina

    Dec 1, 2016, 00:00

  • Interchangeability between Pneumococcal Conjugate Vaccines- A Systematic Review and Meta-Analysis

    Dec 1, 2016, 00:00

  • Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia

    Dec 1, 2016, 00:00

  • Toward Explicit Prioritization for the Caribbean- An EQ-5D Value Set for Trinidad and Tobago

    Dec 1, 2016, 00:00

  • Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile

    Dec 1, 2016, 00:00

  • Erratum

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a Care Program for HIV/AIDS Patients Affiliated with a Health Insurer in Colombia, Comparing Three Health Care Providers Nationwide

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • Costo- Efectividad Del Uso Profiláctico Del Factor Estimulante De Colonias De Granulocitos En Adultos Con Leucemia Linfoblástica Aguda en Colombia

    Dec 1, 2016, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2016, 00:00

  • Measuring and Valuing Informal Care for Economic Evaluation of HIV/AIDS Interventions- Methods and Application in Malawi

    Sep 1, 2016, 00:00

  • Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis- Discrete Choice Experiment among Gastroenterologists

    Sep 1, 2016, 00:00

  • Value and Service Quality Assessment of the National Health Insurance Scheme in Ghana- Evidence from Ashiedu Keteke District

    Sep 1, 2016, 00:00

  • Global Budget for Cyprus’ National Health System- The Promised Land or a No Man’s Land?

    Sep 1, 2016, 00:00

  • Conventionally Fractionationed Volumetric Arc Therapy versus Hypofractionated Stereotactic Body Radiotherapy- Quality of Life, Side Effects, and Prostate-Specific Antigen Kinetics in Localized Prostate Cancer

    Sep 1, 2016, 00:00

  • The Development of the Romanian Scorecard HTA System

    Sep 1, 2016, 00:00

  • Table of Contents

    Sep 1, 2016, 00:00

  • Impact of Health Policy Changes on Trends in the Pharmaceutical Market in Turkey

    Sep 1, 2016, 00:00

  • Copyright/Subscription

    Sep 1, 2016, 00:00

  • Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary- A Retrospective Patient Chart Review

    Sep 1, 2016, 00:00

  • The Effects of the New Methodology Application on the Method of Pricing of Drugs—The Case of the Republic of Macedonia

    Sep 1, 2016, 00:00

  • The Living with Medicines Questionnaire- Translation and Cultural Adaptation into the Arabic Context

    Sep 1, 2016, 00:00

  • Guide for Authors

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania- Implications for other Sub-Saharan African Countries

    Sep 1, 2016, 00:00

  • Performance Assessment of the Juaboso District Office of the National Health Insurance Authority

    Sep 1, 2016, 00:00

  • Cost-Effectiveness Analysis Expands its Reach Worldwide

    Sep 1, 2016, 00:00

  • The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt

    Sep 1, 2016, 00:00

  • The Economic Impact of Cigarette Smoking on the Poor in Jordan

    Sep 1, 2016, 00:00

  • Economic Burden of Osteoporotic Fracture of the Elderly in South Korea- A National Survey

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab in Comparison with Infliximab in Iranian Rheumatoid Arthritis Patients with Inadequate Response to tDMARDs- A Multistage Markov Model

    May 1, 2016, 00:00

  • Table of Contents

    May 1, 2016, 00:00

  • Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia

    May 1, 2016, 00:00

  • Health Technology Assessment, International Reference Pricing, and Budget Control Tools from China’s Perspective- What Are the Current Developments and Future Considerations?

    May 1, 2016, 00:00

  • Importance of Economic Evaluation in Health Care- An Indian Perspective

    May 1, 2016, 00:00

  • ASIA 9C Reviewer Acknowledgment

    May 1, 2016, 00:00

  • Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand

    May 1, 2016, 00:00

  • The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore

    May 1, 2016, 00:00

  • Registration and Reimbursement of New Cancer Medicines in Australia

    May 1, 2016, 00:00

  • Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese Population

    May 1, 2016, 00:00

  • Budget Impact Analysis of Peritoneal Dialysis versus Conventional In-Center Hemodialysis in Malaysia

    May 1, 2016, 00:00

  • Opportunistic Risk Screening for Type 2 Diabetes- Exploring of Application of Diabetes Risk Assessment Tool in Community Pharmacy in Australia and Thailand

    May 1, 2016, 00:00

  • Lifestyle-Related Metabolic Disorders, Osteoporosis, and Fracture Risk in Asia- A Systematic Review

    May 1, 2016, 00:00

  • Erratum

    May 1, 2016, 00:00

  • Guide for Authors

    May 1, 2016, 00:00

  • Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific—Asia-Pacific Burden of Respiratory Diseases Study

    May 1, 2016, 00:00

  • Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China

    May 1, 2016, 00:00

  • Value of Information in Asia- Concepts, Current Use, and Future Directions

    May 1, 2016, 00:00

  • Copyright/Subscription

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis of the Self-Management Program for Thai Patients with Metabolic Syndrome

    May 1, 2016, 00:00

  • Registration and Reimbursement of New Cancer Medicines in Australia—Response to Letter to the Editor by Michael Wonder

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome

    May 1, 2016, 00:00

  • Pharmacoeconomic and Outcomes Research are steadily moving forward in Asia

    May 1, 2016, 00:00

  • Equity in access to high cost drugs in Uruguay

    Dec 1, 2015, 00:00

  • Guide for Authors

    Dec 1, 2015, 00:00

  • Analyses of Budget Impact Considering the Use of the Picture Archiving and Communication System

    Dec 1, 2015, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2015, 00:00

  • Uma análise preliminar do desperdício de quimioterapia No tratamento do câncer

    Dec 1, 2015, 00:00

  • Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia

    Dec 1, 2015, 00:00

  • Costing Dengue Fever Cases and Outbreaks- Recommendations from a Costing Dengue Working Group in the Americas

    Dec 1, 2015, 00:00

  • Comparación de costos y resultados sanitarios de usuarios con neumonia adquirida en comunidad atendidos en domicilio o en hospitalización tradicional- estudio exploratorio de 40 casos

    Dec 1, 2015, 00:00

  • Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011

    Dec 1, 2015, 00:00

  • Evaluating the Long-Term Health Economic Implications of Improving the Proportion of Patients with Type 2 Diabetes Meeting Treatment Targets in Mexico

    Dec 1, 2015, 00:00

  • Epidemiology of Malaria in Latin America and the Caribbean from 1990 to 2009- Systematic Review and Meta-Analysis

    Dec 1, 2015, 00:00

  • Results of the Inclusion of New Medications in the Obligatory Health System Plan in Colombia, 2012–2013

    Dec 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Per ...

    Dec 1, 2015, 00:00

  • Patient-Reported Outcomes in Latin America- Implementation in Research and Role in Emerging HTA Systems

    Dec 1, 2015, 00:00

  • Copyright/Subscription

    Dec 1, 2015, 00:00

  • Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico

    Dec 1, 2015, 00:00

  • Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil- A Multicenter Study

    Dec 1, 2015, 00:00

  • Hospital Variation in Cesarean Delivery- A Multilevel Analysis

    Dec 1, 2015, 00:00

  • Impacto de una Política de Equivalencia Terapéutica en el Precio de Medicamentos en Chile

    Dec 1, 2015, 00:00

  • Table of Contents

    Dec 1, 2015, 00:00

  • Brief Latin American Update- One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia in Guatemala

    Dec 1, 2015, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2015, 00:00

  • Editorial Board

    Sep 1, 2015, 00:00

  • The Potential Effects of Implementing the 2013 ACC/AHA Cholesterol Guidelines on the Use of Statins in a Large Health Maintenance Organization in Israel

    Sep 1, 2015, 00:00

  • A Systematic Review of Community Pharmacists’ Interventions in Reducing Major Risk Factors for Cardiovascular Disease

    Sep 1, 2015, 00:00

  • Table of Contents

    Sep 1, 2015, 00:00

  • Price Determinants of the Tendering Process for Pharmaceuticals in the Cyprus Market

    Sep 1, 2015, 00:00

  • Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary

    Sep 1, 2015, 00:00

  • Project Baiterek- A Patient Access Program to Improve Clinical Outcomes and Quality of Life in Children with Type 1 Diabetes in Kazakhstan

    Sep 1, 2015, 00:00

  • An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate Health State Values in the United Arab Emirates

    Sep 1, 2015, 00:00

  • High-Quality, Scientific Rigor, and Diversity- Value in Health Regional Issues Is Getting Its Impact

    Sep 1, 2015, 00:00

  • Copyright/Subscription

    Sep 1, 2015, 00:00

  • Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia

    Sep 1, 2015, 00:00

  • Health-Related Quality-of-Life Measures- Evidence from Tunisian Population Using the SF-12 Health Survey

    Sep 1, 2015, 00:00

  • Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

    Sep 1, 2015, 00:00

  • Patterns of Care and Treatment Target Success among Persons with Type 2 Diabetes Mellitus in Dubai- A Retrospective Cohort Study

    Sep 1, 2015, 00:00

  • Economic Impact and Complications of Treated and Untreated Hepatitis C Virus Patients in Turkey

    Sep 1, 2015, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »